Namrata Vijayvergia

Research Inst Of Fox Chase Can Ctr

$306,731

Attributed

$613,462

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $429.2K · FY2020–25

$500K$375K$250K$125K$0

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$613,462 · 2

By mechanism

R21$429,162 · 1

R03$184,300 · 1

Top collaborators

Jordan Mossler Anaokar2 shared
Sara J. Ward1 shared

Most similar at Research Inst Of Fox Chase Can Ctr

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Incidence”

Yunda Huang · Fred Hutchinson Cancer Center$53,742,512
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,703,204
Susan Abushakra · Alzheon, Inc.$47,265,244
Julie Ake · National Institute Of Allergy And Infectious Diseases$39,792,120
Christopher Barnaby Nelson · University Of Melbourne$27,954,628
Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420

Research focus

IncidenceRandomizedResearch PersonnelPhase 2 StudyProspectiveProtocols DocumentationPilot ProjectsImaging BiomarkerImageImaging ModalityGastrointestinal Stromal TumorsHospitalsAdvanced DiseaseBlood VesselsEvaluationEarly Detection BiomarkersFollow-UpCommunitiesAssessment ToolCapecitabineBaseEastern Cooperative Oncology GroupAmerican College Of Radiology Imaging NetworkAppearance

Grant awards (3)

Exploring the Neuroprotective Potential of CBD in Preventing Oxaliplatin-Induced Neuropathy: A Prospective Study$429,162

R21 · FY2025 · CA · contact PI

Systematic study of variations in imaging techniques and response criteria for well differentiated pancreatic neuroendocrine tumors$92,150

R03 · FY2021 · CA · contact PI

Systematic study of variations in imaging techniques and response criteria for well differentiated pancreatic neuroendocrine tumors$92,150

R03 · FY2020 · CA · contact PI